![]() | |
Clinical data | |
---|---|
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider |
|
UNII | |
KEGG |
|
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C14H21N |
Molar mass | 203.329 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
PCE (Eticyclidine, CI-400) is a dissociative anesthetic drug with hallucinogenic effects. It is similar in effects to phencyclidine but is slightly more potent. PCE was developed by Parke-Davis in the 1970s and evaluated for anesthetic potential under the code name CI-400, [2] but research into PCE was not continued after the development of ketamine, a similar drug with more favourable properties. [3] Due to its similarity in effects to PCP, PCE was placed into the Schedule 1 list of illegal drugs in the 1970s, although it was only briefly abused in the 1970s and 1980s and is now little known.
Inhalational | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Injection |
| ||||||||||||||
|
D1-like |
| ||||||
---|---|---|---|---|---|---|---|
D2-like |
| ||||||
AMPAR Tooltip α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor |
|
---|---|
KAR Tooltip Kainate receptor |
|
NMDAR Tooltip N-Methyl-D-aspartate receptor |
|
![]() | This hallucinogen-related article is a stub. You can help Wikipedia by expanding it. |